Welcome to the EPA 2021 Interactive Programme

The viewing of sessions and E-Posters cannot be accessed from this conference calendar. All sessions and E-Posters are accessible via the Main Lobby in the virtual platform.

The congress will officially run on Central European Summer Time (CEST)

To convert the congress times to your local time Click Here

Fully Live with Live Q&A On Demand with Live Q&A  ECP Session Section Session EPA Course (Pre-Registration Required) Product Theatre

   Sessions with Voting  Ask the Expert  Live TV

                 

Browsing Over 167 Sessions

Sort By Relevance
EPA Course
Date
Tue, 13.04.2021
Session Time
08:00 - 10:00
Room
Courses Hall B
Session Description
This course should be taken as part of the current innovative approach to psychotherapy, directed to address masses of people who might need psychological assistance. This approach is based on principles of the 3rd wave CBT and of Low Intensity CBT Interventions (LICBT-I). This course will present a universal short protocol mainly based on Acceptance and Commitment Therapy approach, created for psychotherapy and implemented and adapted to a resilience prevention intervention. Based on the therapeutic protocol, an intervention that integrates emotional, physiological and cognitive behavioral techniques as well as attentional regulation, mainly mindfulness, was developed to build resilience and prevention in the community. Thousands of teachers and counselors have trained, to deliver resilience to their students (~1,000,000 nationwide). The program has been endorsed by the Ministry of Education of Israel to be part of the regular curriculum of every school. A series of empirical studies has shown the effectiveness of the program. This cost-effective approach, delivered by the teachers as mediators decreased by 50% the development of posttraumatic responses in children following severe stressful exposure. Based on this program we have developed and implemented resilience programs for different populations (e.g., parents and educational staff of infants in day-care centers and autistic kids, adolescents at risk, students in the university, medical stuff, and the elderly). The intervention is adapted to different cultures (Israeli Muslims, Refugees from Africa, Orthodox religious Jews and a pilot in schools in Norway).
Session Icon
Live, Ticket Required
Clinical/Therapeutic
Date
Tue, 13.04.2021
Session Time
08:00 - 09:30
Room
Channel 6
Session Description
The Live Q&A of this session will take place in the Live Sessions auditorium. Please refer to the interactive programme for the exact time and channel.

Proposed by the EPA Section on Neuroimaging and Epidemiology and Social Psychiatry -Refining our understanding of developmental trajectories of mental disorders will allow us to identify early those patients most likely to develop persistence impairment in mental health as well as those patients which will benefit most from treatment. Because of the limited viability of treating all cases, it is particularly important to find out individual determinants predisposing to worst outcome or to a better response to treatment. The key role of social and environmental risk factors, within a gene-environment interplay framework, in precipitating and maintaining specific trajectories in mental disorders will be pointed out in different representative samples. In the same way, alterations in neurobiology and neuroimaging biomarkers which have been associated to developmental patterns leading to different mental health outcome will be critically revised in the light of recent evidence-based results.

Session Icon
Pre-Recorded with Live Q&A, Section
EPA Course
Date
Tue, 13.04.2021
Session Time
17:30 - 19:30
Room
Courses Hall A
Session Description
Proposed by the EPA Section on TeleMental Health - Telemental health care or Telepsychiatry (TP) is the use of telecommunication and information technologies to deliver psychiatric and mental health services at a distance. The evidence-base for this field of psychiatry has rapidly grown, over the past years. Evidence related to faculty and trainee competencies is strong for TP direct service and consultation to primary care. Promising evidence is accumulating also for asynchronous video and Internet-based cognitive behavioral therapy. New research fields concerning technology-based self-help and support groups, clinical use of social media, smartphone apps for self-care (e.g., anxiety and depression management) and other e-mental health applications are also rapidly emerging. TP interventions increase access to mental healthcare, result in quality of care equivalent to in-person care and often reduce costs. Competencies that focus on skills, more than knowledge, can help clinicians adjust to differences with in-person care, ensure quality, and prevent and manage potential challenges (e.g., boundary, privacy and other regulatory issues; barriers to assessment; therapeutic barriers). Telemental health care (spanning across psychiatry, psychology, social work, counseling, marriage and family) and social media competences are today necessary also in routine settings. The course will provide a knowledge base about TP, a rationale for use of TP approach in a variety of psychiatric settings and practical hints about how to deliver TP care in a wide range of populations. The course will be organized in collaboration with the EPA Early Career Psychiatrists Committee and its Chair (M. Pinto da Costa) will act as a Course Facilitator.
Session Icon
Live, Sessions with Voting, Ticket Required, Section
EPA Course
Date
Sat, 10.04.2021
Session Time
14:00 - 16:00
Room
Courses Hall A
Session Description
Attention-Deficit/Hyperactivity Disorder (ADHD) is a chronic neurodevelopmental disorder that is characterized by attentional problems, deficient impulse control, hyperactivity and often also by emotional dysregulation. ADHD has its onset in childhood and affects approximately 5% of children. In over half of the individuals with ADHD, symptoms persist into adulthood and even old age. World-wide, ADHD in adulthood is under-recognised and under-treated. Undiagnosed or untreated ADHD in adulthood is problematic, because it often co-occurs with other psychiatric and somatic illnesses. Among the most prevalent ones are major depression, anxiety, substance use and obesity. These comorbid conditions considerably contribute to the disease burden of individuals, as well as to healthcare costs. In many instances, individuals with ADHD drop out of psychiatric healthcare in the transition from childhood to adult services. Later in life, they often return with symptoms of comorbid conditions; their ADHD often is not recognised at that point and there is a danger that they might receive treatments for their comorbid problems without awareness and adequate care for the underlying ADHD. Providing care throughout the lifespan, but especially in young adults, may therefore be pivotal to reducing this negative developmental trajectory later in life. In this course, experts in adult ADHD will inform clinical psychiatrists about the prevalence and characteristics of ADHD in adulthood and its most common comorbid conditions across the lifespan. Using real life examples of cases, participants will practice how to diagnose ADHD in the context of comorbidity, and discuss different (pharmacological and non-pharmacological) treatment and psychotherapy options.
Session Icon
Live, Ticket Required
Mental Health Policy
Date
Tue, 13.04.2021
Session Time
17:30 - 19:00
Room
Channel 3
Session Description
The Live Q&A of this session will take place in the Live Sessions auditorium. Please refer to the interactive programme for the exact time and channel.

Proposed by the EPA Section on Mental Health and Intellectual Disability -The International Classification of Functioning, Disability and Health (ICF) is a taxonomy of health and health-related domains. It provides a common language and framework for describing the level of functioning of a person within their unique environment. Furthermore, it helps to describe health problems of a person in line with the International Classification of Diseases (ICD-10). ICF aims to provide a patient-centred approach to the assessment and management of people with chronic health conditions, mental disorders and intellectual disabilities (ID) by defining individual therapeutic goals and monitoring functional outcomes. The ICF also plays an important role in psychiatric rehabilitation, describing health problems due to mental illnesses and neurodevelopmental disorders. ICF facilitates a comprehensive multidisciplinary approach to assess an individual’s level of functioning and care. Use of a standardised classification system to assess and document biopsychosocial function helps to further support provision of high-quality individualised health and social care. Furthermore, ICF provides a standardised assessment instrument to determine individual functional needs for the care, rehabilitation and societal integration of individuals with disabilities which is a statutory requirement in many European countries. For example, in Germany, the revision of the Federal Participation Act (BTHG) requires the use of ICF as a standardised assessment instrument for determining individual functional needs of individuals with ID. Main objective of the workshop is to introduce the ICF and discuss its advantages and limitations in clinical practice, research, psychiatric treatment and care of individuals with ID and mental health problems.

Session Icon
Pre-Recorded with Live Q&A, Section
EPA Course
Date
Mon, 12.04.2021
Session Time
15:00 - 17:00
Room
Courses Hall A
Session Description
Peer support work is an important part of mental health care. This is a particularly useful approach in inpatient settings where patients’ interactions with family, friends and others outside the care setting may be limited. Peer support work is beneficial for both patients and peer supporters themselves, as this bridges staff-patient gaps. Peer supporters are able to share positive experiences with patients and patients might find it helpful to receive support from someone they feel they can relate to. Peer support has a long tradition but is still novel in many mental health settings. This course will guide participants through the process of involving peer support workers within an inpatient care setting. It will present factors that may help or hinder this process. Special attention will be paid to organizational culture, the role of team leaders, attitudes of staff and patients, and administrative hurdles. This course will discuss some of the difficulties of involving peer support workers in specialized settings, such as forensic mental health clinics. It is important that peer supporters are themselves supported throughout this process, especially if they are new. Therefore, the course will address approaches to maintaining the wellbeing and occupational health of peer supporters. Participants will be given learning materials and vignettes that encourage them to reflect on how peer support may be implemented or sustained in their own care settings.
Session Icon
Live, Ticket Required
Mental Health Policy
Date
Mon, 12.04.2021
Session Time
10:00 - 11:30
Room
Channel 7
Session Description
The Live Q&A of this session will take place in the Live Sessions auditorium. Please refer to the interactive programme for the exact time and channel.

The shortage of child and adolescent psychiatrists is a global crisis. Much attention has been given to solutions to the unmet need for child mental health services. One of the four priorities for the next decade of child psychiatry outlined in 2019 by a workgroup of psychiatric leaders of international groups is to expand the workforce beyond the direct training of child psychiatrists to other healthcare professionals. (Skokauskas 2019). Project ECHO (Extension for Community Health Care Outcomes) has been a promising model of workforce expansion. It uses the approaches of high quality CME and integration by combining collaborative cased based consultation with didactic instruction delivered virtually. The initial success of this model has led to its global expansion.(VanCleave 2017) This workshop will demonstrate the efficacy of ECHO as a workforce multiplier by describing its use to address child psychiatry shortages in four different countries. An opportunity for general questions and discussion of developing ECHO programs will follow brief presentations. Dr. Pajer will describe Project ECHO Ontario(CYMH) which has trained 500 primary care and mental health providers. Dr. Leppert will discuss KKI-NECT(US) which addresses early childhood mental health and development. Dr. Newcomb will describe ECHOs targeting general practitioners and non-medical staff in Queensland Australia. Dr. Dharmadhikari will discuss using ECHO to train general psychiatrists in rural India. Dr. Gardner’s presentation of operational outcomes will open the discussion about developing of ECHO programs (funding, operationalization, evaluation). All of the presenters will describe adaptations to their programs to address COVID-19 related concerns.

Session Icon
Pre-Recorded with Live Q&A
Date
Sun, 11.04.2021
Session Time
08:00 - 09:30
Room
Channel 4
Session Description
The Live Q&A of this session will take place in the Live Sessions auditorium. Please refer to the interactive programme for the exact time and channel.

The molecular factors involved in the pathophysiology of major depressive disorder (MDD) and related endophenotypes remain poorly understood. The complexity of the MDD phenotype may contribute to inconsistent results. Dr Mara Dierssen will do an overview concerning transcriptional factor mechanisms underpinning of neurodevelopmental disorders. One recent approach to examine the molecular basis of MDD is co-expression network analysis, which facilitates the examination of complex interactions between expression levels of individual genes and how they influence biological pathways that could be affected in MDD. Dr Bernhard Baune will present recent findings supporting dysregulated immune response and protein processing in the endoplasmic reticulum in MDD, thus providing novel insights into the pathophysiology of depression. Genome-wide transcriptome analysis of MDD patients clinically well characterize as well as of relevant risk phenotypes such as childhood traumatic experiences could represent an advance in this field. Dr Alessandra Minelli will present results from a transcriptomic study on the effect of childhood traumas. Moreover, she will show the role of environmental and genetic factors on the identified dysregulations. Based on the hypothesis that MDD could be characterized by accelerated aging, Dr Alessio Squassina investigated the role of telomere length and inflammation in this disorder. Findings showed that MDD patients have shorter telomeres compared to controls, and that treatment-resistant patients have higher levels of TNFα than non-TRD and controls, suggesting that TR might be associated with increased inflammation.

Session Icon
Pre-Recorded with Live Q&A
Clinical/Therapeutic
Date
Mon, 12.04.2021
Session Time
08:00 - 09:30
Room
Channel 7
Session Description
The Live Q&A of this session will take place in the Live Sessions auditorium. Please refer to the interactive programme for the exact time and channel.

The novel coronavirus pandemic 2019 (COVID-19) is posing new critical challenges in many areas of mental health worldwice, such as: 1) widespread social alarm, with an overall increase of anxiety states, somatic concerns, and mood sensitivity; 2) long-lasting physical distancing due to both the response to public health protection rules and also voluntary conduct. The interaction of such conditions sharply increases the risk of inducing or reinforcing some features of conduct disorders, such as behavioural addictions. To go in-depth into the psychosocial meaning of these conducts is quite timely and potentially urgent from a clinical point of view. Addictive conducts born or reinforced in a long-lasting self-distancing condition may grow over time and root themselves also in a future normalized situation. Some behavioural risks must be considered: a) increased time spent using Internet, with very frequent development of mild to severe forms of addiction, including a compulsive need to be in touch with other people, increased/addicted use of social media., anxiety reaction when not online, etc.) onset/increase of specific Internet-use profiles with high addictive risk, such as online gambling, gaming, shopping; most common forms of internet use may become problematic in distressed self-distancing conditions; c) increased time of physical exercise at home with compulsive features, in people with a previous profile of exercise addiction and also the lack of access to a specific sports addiction; d) possible influence on course and shaping of previously existent or newly induced features of mental disorders.

Session Icon
Pre-Recorded with Live Q&A
Mental Health Policy
Date
Sun, 11.04.2021
Session Time
08:00 - 09:30
Room
Channel 6
Session Description
The Live Q&A of this session will take place in the Live Sessions auditorium. Please refer to the interactive programme for the exact time and channel.

Transgender people represent a broad spectrum of individuals that transiently or persistently identify with a gender different from the one assigned at birth (APA, 2013). Transgender healthcare issues have become an increased matter of interest over the last years, as shown by the growth of publications on the subject and by the increase of referrals reported worldwide in all age groups. However, transgender people report encountering numerous obstacles in accessing and receiving appropriate health care with professionals being described as not properly trained on specific gender issues. Considering the diversity and complexity of the gender spectrum in the different age groups, and in light of the recent changes in the formal psychiatric classification, mental health providers play a critical role in meeting the needs of gender non-conforming children, adolescents and adults, according to individualized paths. This course has the following aims: (1) learn the principles of assessment of gender incongruence in childhood, adolescence and adulthood; (2) address co-occurring psychopathology; (3) identify different treatment paths according to age and individualized psychological and/or medical needs; (4) work in a multidisciplinary team in line with an integrated model. Each area will be considered in the four presentations of the course. Then, video of cases will be presented, and small groups of discussion will be organized. In particular, two of the speakers are actively involved in the revision committee for the Standards of Care of the World Professional Association for Transgender Health (SOC 8); thus they will provide recent updates on this topic.

Session Icon
Pre-Recorded with Live Q&A
Mental Health Policy
Date
Mon, 12.04.2021
Session Time
17:30 - 19:00
Room
Channel 6
Session Description
The Live Q&A of this session will take place in the Live Sessions auditorium. Please refer to the interactive programme for the exact time and channel.

Recently, the discussion on physician aid-in-dying (PAD) extended to the context of mental disorders. Supporters of that view mainly argue based on patient autonomy. In Switzerland the Swiss Academy of Medical Sciences (SAMW) updated their recommendation, replacing the requirement of terminality with the criteria of unbearable suffering. This would allow people suffering from mental illness to access PAD. However, the Swiss Medical Association (FMH) decided not to adopt this recommendation and to restrict PAD to cases of terminal illness. In Germany, in 2020 the Federal Constitutional Court ruled that the right to self-determined death, including the freedom to seek assistance for suicide, if available, is a civil right. The implications of these decisions for legislation and practice on PAD in general and mental disorders in particular are not fully conceivable yet. The discourse about defining severe suffering and terminal illness in psychiatry is complex and challenges legal, ethical and professional positions on both an individual and a collective level. Suffering is a necessary but insufficient condition for PAD in psychiatry, the other criteria being decision-making capacity and refractoriness of the suffering. Additionally it has to be taken into account that suffering is a subjective experience that can only be quantified by the patient. The symposium aims to focus on the discussion of conditions under which severe mental illness might lead to such a pronounced and unbearable state of suffering, with no prospect of therapeutic improvement that - after a conscientious assessment - PAD can be considered.

Session Icon
Pre-Recorded with Live Q&A
Educational
Date
Tue, 13.04.2021
Session Time
15:30 - 17:00
Room
Channel 3
Chair(s)
Session Description
The Live Q&A of this session will take place in the Live Sessions auditorium. Please refer to the interactive programme for the exact time and channel.

Psychiatrists are often expected to be experts on suicide prevention however, curriculum contents on the management of suicidal persons and suicide prevention might vary between universities during medical education. ELLIPSE (E-Lifelong Learning In Prevention of Suicide In Europe), an innovative project co-funded by the Erasmus+ programme of the European Union, with 8 partners from 5 countries (Sweden, Austria, Hungary, Norway, Poland) will be presented. Its aim is to develop a European online training program in suicide prevention for the higher education sector; to increase knowledge and to professionalize attitudes and skills of students in suicide prevention. Workshop participants will have an opportunity to follow the different stages in the development of the European e-learning program ELLIPSE, as well as to learn about French experiences with MOOCs, online courses on suicidal behaviour. They will be invited to share ideas on the future European guidelines in the education on suicide prevention, which may become an important complement to ongoing efforts in the transformation of mental health services in Europe.

Session Icon
Pre-Recorded with Live Q&A